One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN
Anat Yerushalmy-Feler, MD,* Christine Olbjorn, MD, PhD,†Kaija-Leena Kolho, MD, PhD, ‡,§ Marina Aloi, MD, PhD, ¶, Francesca Musto, MD,¶ Javier Martin-de-Carpi, MD, PhD, || Ana Lozano-Ruf, MD,|| Dotan Yogev, MD,** Manar Matar, MD,††Luca Scarallo, MD,‡‡ , Matteo Bramuzzo, MD, §§, Lissy de Ridder, MD, PhD, ¶¶ Ben Kang, MD, PhD, |||| Christoph Norden, MD,*** David C. Wilson, MB BCh, MD,†††Christos Tzivinikos, MD,‡‡‡ Dan Turner, MD, PhD,** and Shlomi Cohen, MD
doi : 10.1093/ibd/izad064
Volume 30, Issue 2, February 2024
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Laila Aldars-Garc?a, PhD,* Rubén Gil-Redondo, MS,†Nieves Embade, PhD, †Sabino Riestra, MD, ‡ Montserrat Rivero, MD,§ Ana Gutiérrez, MD, PhD, ¶ Iago Rodr?guez-Lago, MD, PhD,? Luis Fern?ndez-Salazar, MD,** Daniel Ceballos, MD, ††, José Manuel Ben?tez, MD, ‡‡ Mariam Aguas, MD, PhD,§§ Iria Baston-Rey, MD,¶¶ Fernando Bermejo, MD, PhD,??, Mar?a José Casanova, MD, PhD,* Rufo Lorente, MD,*** Yolanda Ber, MD, †††Daniel Ginard, MD,‡‡‡ Mar?a Esteve, MD,§§§ Ruth de Francisco, MD,‡ Mar?a José Garc?a, MD,§ Rubén Francés, MD, PhD,** Ainhoa Rodr?guez Pescador, MD,? Benito Velayos, MD,** Elena Guerra del R?o, MD,††Sandra Mar?n Pedrosa, MD,‡‡ Alejandro Minguez Sabater, MD, §§ Manuel Barreiro-de Acosta, MD, PhD,¶¶ Alicia Algaba, PhD,?? Cristina Verdejo Gil, MD,*** Olga Rivas, MD,†††Vanesa Royo, MD, ‡‡‡ Montserrat Aceituno, MD,§§§ Ana Garre, MS,* Montserrat Bald?n-Mart?n, PhD,* Cristina Ram?rez, BS,* Ancor Sanz-Garc?a, PhD,??? Juan J. Lozano, PhD,**** Julia Sidorova, PhD,**** Oscar Millet, PhD, †David Bernardo, PhD,††††,‡‡‡‡ Javier P. Gisbert, MD, PhD,*,a and Mar?a Chaparro, MD, PhD
doi : 10.1093/ibd/izad154
The Incidence of Pouch Neoplasia Following Ileal Pouch–Anal Anastomosis in Patients With Inflammatory Bowel Disease
Siri A. Urquhart, MD,*, Bryce P. Comstock, BA,†Mauricio F. Jin, BS,†Courtney N. Day, MS,‡ , John E. Eaton, MD,* William S. Harmsen, PhD, ‡ Laura E. Raffals, MD,* Edward V. Loftus Jr., MD, * and Nayantara Coelho-Prabhu, MD
doi : 10.1093/ibd/izad021
Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study
Thomas M. Goodsall, MSc,*,†, Alice S. Day, PhD,†,‡ Jane M. Andrews, PhD,†,‡, Andrew Ruszkiewicz, § Christopher Ma, MD,¶,||, and Robert V. Bryant, PhD
doi : 10.1093/ibd/izad043
The Safety of Dilation of Ileoanal Strictures With Mechanical or Balloon Dilation Is Similar Among Patients After Ileal Pouch–Anal Anastomosis
Kimberly Darlington, MD, PhD,*,a Annmarie Wang, BS ‡,a Hans H. Herfarth, MD, PhD,*,†,§ Edward L. Barnes, MD, MPH
doi : 10.1093/ibd/izad051
Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases
Joseph Carter Powers, BA,*, Benjamin L. Cohen, MD,†Florian Rieder, MD,†Benjamin H. Click, MD,‡ Ruishen Lyu, MS,§ Katherine Westbrook, DO,¶ Tracy Hull, MD, ? Stefan Holubar, MD,?, Miguel D. Regueiro, MD,†and Taha Qazi, MD
doi : 10.1093/ibd/izad054
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN
Ohad Atia, MD,*,a, Ramit Magen Rimon, MD,†,a, Natan Ledderman, MD,‡ Shira Greenfeld, MD, §,¶ Revital Kariv, MD,§,¶ Yiska Loewenberg Weisband, MD, || Ron Shaoul, MD,†Eran Matz, MD,** Shmuel Odes, MD,††Idan Goren, MD, ¶,‡‡,§§, Henit Yanai, MD, ¶,§§ Iris Dotan, MD, PhD,¶,§§ and Dan Turner, MD, PhD
doi : 10.1093/ibd/izad057
Time to Diagnosis and Birth Outcomes of Pregnancy-onset IBD
Thea Vestergaard, MD,*,†, Julie R?sok, MD,* Mette Julsgaard, PhD,*,†,¶, Rikke Bek Helmig, PhD, ‡ Sonia Friedman, MD,§ and Jens Kelsen, PhD
doi : 10.1093/ibd/izad059
Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Yakup Kilic, MD,* Shahed Kamal, MBBS, †Farah Jaffar, MBBS,‡ Danujan Sriranganathan, MBBS,§, Mohammed Nabil Quraishi, MB, ChB, PhD,¶ and Jonathan P. Segal, MB, ChB, PhD
doi : 10.1093/ibd/izad061
In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab
Jean-Philippe Loly, MD,*, Sophie Vieujean, MD, PhD,*, Catherine Reenaers, MD, PhD,* Catherine Van Kemseke, MD, PhD,* Laurence Seidel, ScD,†Edouard Louis, MD, PhD,* and Joan Somja, MD, PhD
doi : 10.1093/ibd/izad066
Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study
Julie Rasmussen, MD,*,†, Bente Mertz N?rg?rd, MD, PhD, DMSc,‡,§, Rasmus Gaardsk?r Nielsen, MD, PhD,¶,? Henrik B?ggild, MD, PhD,**,††Niels Qvist, MD, DMSc,?,‡‡, René B?rge Korsgaard Brund, PhD,* Niels Henrik Bruun, MSc,††and Kirsten Fonager, MD, PhD
doi : 10.1093/ibd/izad157
Ulcerative Colitis Is Associated With Diet-related Inflammation and Physical Activity in the IBD Partners E-cohort
Kelli E. DuBois, PhD,*,†, Christine E. Blake, PhD, RD, †Caroline Rudisill, MSc, PhD,†Sayward E. Harrison, PhD,‡ Michael D. Wirth, PhD, §,¶,?,** and James R. Hébert, ScD
doi : 10.1093/ibd/izad139
Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis
Marco Valvano, MD,*, Marco Magistroni, MD,* Nicola Cesaro, MD,* Giorgio Carlino, MD,* Sabrina Monaco, MD,* Stefano Fabiani, MD,* Antonio Vinci, MD, †Filippo Vernia, MD,* Angelo Viscido, MD, PhD,* and Giovanni Latella, MD
doi : 10.1093/ibd/izac253
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review
Javier P. Gisbert,PhD,*, Elizabeth Parody-R?a, PhD,†, and Mar?a Chaparro, PhD
doi : 10.1093/ibd/izac275
Research Progress of Interleukin-27 in Inflammatory Bowel Disease
Qing Wang, MD,* Feifan Chen, MD,* Yingqiu Peng, MD, * Xuanyu Yi, MD,* Yu He, MD,* and Yuan Shi, MD
doi : 10.1093/ibd/izad153
Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy
Emily C.L. Wong, BHSc,* Parambir S. Dulai, MD, †, John K. Marshall, MD, MSc,* Vipul Jairath, MD, PhD,‡ Walter Reinisch, MD, PhD, § and Neeraj Narula, MD, MPH
doi : 10.1093/ibd/izad077
Early Onset Sepsis and Lobar Pneumonia in a Newborn Exposed In Utero to Ustekinumab and Azathioprine
C?cilie Skej?, MD,* Signe Thim, MD, PhD,†Anna Sellmer, MD, PhD, †and Mette Julsgaard, MD, PhD
doi : 10.1093/ibd/izad303
Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle
Zhigang Wang, PharmD and Erwin Dreesen, MSc, PharmD, PhD
doi : 10.1093/ibd/izad152
The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients
Antonius T. Otten, MD, *, Gerard Dijkstra, MD, PhD,* Marijn C. Visschedijk, MD, PhD,* and Arno R. Bourgonje, MD, PhD*,â€
doi : 10.1093/ibd/izad144
Think Again Before Resecting an Organ: Appendectomy or Endoscopic Retrograde Appendicitis Therapy?
Yang Shi, MD, PhD , Saif Ullah, MD , and Bing-Rong Liu, MD, PhD
doi : 10.1093/ibd/izad208
Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?
Simon Erridge, MBBS, BSc, *,†, and Mikael H. Sodergren, MBChB, DIC, PhD, FRCS*,â€
doi : 10.1093/ibd/izad221
